Cost Of Revenue - Cytosorbents Corp (NASDAQ:CTSO) - Alpha Spread

Cytosorbents Corp
NASDAQ:CTSO

Watchlist Manager
Cytosorbents Corp Logo
Cytosorbents Corp
NASDAQ:CTSO
Watchlist
Price: 1.42 USD Market Closed
Market Cap: 77.1m USD
Have any thoughts about
Cytosorbents Corp?
Write Note

Cytosorbents Corp
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cytosorbents Corp
Cost of Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Cytosorbents Corp
NASDAQ:CTSO
Cost of Revenue
-$13.2m
CAGR 3-Years
-7%
CAGR 5-Years
-11%
CAGR 10-Years
-17%
Becton Dickinson and Co
NYSE:BDX
Cost of Revenue
-$10.8B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
-10%
Boston Scientific Corp
NYSE:BSX
Cost of Revenue
-$4.7B
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
-8%
Stryker Corp
NYSE:SYK
Cost of Revenue
-$7.7B
CAGR 3-Years
-10%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
Abbott Laboratories
NYSE:ABT
Cost of Revenue
-$18.2B
CAGR 3-Years
-1%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cost of Revenue
-$2.5B
CAGR 3-Years
-16%
CAGR 5-Years
-15%
CAGR 10-Years
-15%

See Also

What is Cytosorbents Corp's Cost of Revenue?
Cost of Revenue
-13.2m USD

Based on the financial report for Jun 30, 2024, Cytosorbents Corp's Cost of Revenue amounts to -13.2m USD.

What is Cytosorbents Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-17%

Over the last year, the Cost of Revenue growth was 15%. The average annual Cost of Revenue growth rates for Cytosorbents Corp have been -7% over the past three years , -11% over the past five years , and -17% over the past ten years .

Back to Top